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GRK2 is an important protein involved in β-adrenergic receptor desensitization. In 38 
addition, studies have shown GRK2 can modulate different metabolic processes in the 39 
cell.  For instance, GRK2 has been recently shown to promote mitochondrial biogenesis 40 
and increase ATP production.  However, the role of GRK2 in skeletal muscle and the 41 
signaling mechanisms that regulate GRK2 remain poorly understood.  Myostatin is a 42 
well-known myokine that has been shown to impair mitochondria function. Here, we 43 
have assessed the role of Myostatin in regulating GRK2 and the subsequent downstream 44 
effect of Myostatin regulation of GRK2 on mitochondrial respiration in skeletal muscle.   45 
Myostatin treatment promoted the loss of GRK2 protein in myoblasts and myotubes in a 46 
time- and dose-dependent manner, which we suggest was through enhanced ubiquitin-47 
mediated protein loss, as treatment with proteasome inhibitors partially rescued 48 
Myostatin-mediated loss of GRK2 protein. To evaluate the effects of GRK2 on 49 
mitochondrial respiration, we generated stable cell myoblasts lines that overexpress 50 
GRK2.  Stable overexpression of GRK2 resulted in increased mitochondrial content and 51 
enhanced mitochondrial/oxidative respiration. Interestingly, although overexpression of 52 
GRK2 was unable to prevent Myostatin-mediated impairment of mitochondrial 53 
respiratory function, elevated levels of GRK2 blocked the increased autophagic flux 54 
observed following treatment with Myostatin. Overall, our data suggest a novel role for 55 
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G protein-coupled receptor kinases (GRKs) are serine/threonine kinases initially 66 
identified to participate in the process of G protein-coupled receptor desensitization 67 
(53).  GRKs comprise a family that can be partitioned into three groups through 68 
sequence homology: GRK1/7; GRK2/3 and GRK4/5/6 (54).  GRK1 and 7 are found in 69 
retinal rods and cones, respectively, and GRK4 is expressed in testis, cerebellum and 70 
kidney (38, 53-55).  However, ubiquitous expression of GRK2, 3, 5 and 6 is observed in 71 
mammalian tissues (53-55).  These kinases can phosphorylate specific amino acid 72 
residues in the intracellular domain of activated receptors and lead to recruitment of 73 
adaptor proteins (e.g. β-arrestins) in order to attenuate intracellular G protein signaling 74 
(54, 63). 75 
Recent studies have identified GRK2 as an emerging kinase involved in 76 
regulating different cellular process through phosphorylation and/or association with 77 
other proteins (13, 23, 26, 72).  Moreover, GRK2 expression and activity is tightly 78 
regulated and is altered during several pathological conditions, for example 79 
hypertension, heart failure and inflammation (41, 49, 75).  GRK2 has recently been 80 
linked to mitochondrial function and biogenesis (18). Overexpression of GRK2 has 81 
been shown to promote increased mitochondrial mass and further enhance ATP 82 
production due to the ability of GRK2 to target and phosphorylate mitochondrial 83 
proteins in HEK293 cells; whereas knockdown of GRK2 led to reduced ATP 84 
production in skeletal muscle (18).  Moreover, macrophages treated with LPS exhibited 85 
enhanced GRK2 accumulation in mitochondria, which was associated with increased 86 
mtDNA copy and reduced ROS production (65).  Although several studies have helped 87 
to delineate GRK2 function using different model systems, the function of GRK2 in 88 
skeletal muscle metabolism remains to be fully elucidated. 89 
Members of the TGF-β superfamily of secreted growth factors, including 90 
GDF11 and Myostatin, have negative impact on skeletal muscle growth and 91 
maintenance (11, 45).  More specifically, Myostatin has been previously shown to 92 
inhibit myoblast proliferation (58, 69), myogenic differentiation (27, 33), block protein 93 
synthesis signaling and promote a reduction in myotube size (70). Moreover, elevated 94 
levels Myostatin has been shown to promote loss of mitochondrial membrane potential 95 
and impair mitochondrial function in cancer cells (39). Importantly, Myostatin is a 96 
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potent inducer of skeletal muscle wasting and increased Myostatin activity has been 97 
observed in different atrophic conditions (1, 42, 56). 98 
Over the past 10 years, many studies have revealed the pathological mechanisms 99 
involved in Myostatin-mediated atrophy in skeletal muscle.  Specifically, McFarlane et 100 
al. (2006) reported that Myostatin was able to block IGF1/PI3K/Akt signaling and 101 
activate the transcription factor FoxO1, which increases the expression of 102 
MAFbx/Atrogin-1 and MuRF1/Trim63 (44), two well-known muscle-specific E3 103 
ligases that are associated with muscle atrophy (2, 12).  Myotubular atrophy has also 104 
been noted in human myotubes upon treatment with excess Myostatin (32, 40), which 105 
was associated with increased levels of Atrogin-1 and MuRF1 (40).  Additional work 106 
has revealed that Myostatin signals through Smad3 to increase FoxO1 and Atrogin-1 to 107 
promote the ubiquitination and subsequent loss of critical sarcomeric proteins, such as 108 
myosin heavy chain (MyHC), during muscle wasting (40). 109 
As GRK2 and Myostatin have been shown to regulate mitochondrial function we 110 
sought to determine a potential role for Myostatin in regulating GRK2 and subsequent 111 
mitochondrial respiration in skeletal muscle.  In this report, we show that Myostatin 112 
targets and suppresses GRK2 protein levels in muscle cells, through a mechanism 113 
involving the ubiquitin-proteasome pathway.  In the present study, we find that 114 
Myostatin treatment leads to impaired mitochondrial respiration, which was associated 115 
with mitochondrial fragmentation, enhanced autophagic flux and reduced mitochondrial 116 
content in muscle cells.  We have further unraveled a novel role for GRK2 in regulating 117 
mitochondrial respiration in muscle cells. Overexpression of GRK2 in myoblasts also 118 
led to increased mitochondrial fragmentation; however, unlike Myostatin, GRK2 119 
overexpression was associated with enhanced mitochondrial respiration and increased 120 
mitochondrial mass. Surprisingly, while overexpression of GRK2 was not able to 121 
overcome the negative effect of excess Myostatin on mitochondria respiration; elevated 122 
GRK2 levels resulted in increased mitochondria content and a reduction in the overt-123 
autophagic flux noted in the presence of excess Myostatin. Overall, these data reveal a 124 
novel role for GRK2 in regulating mitochondrial respiration and mass in muscle cells 125 
and reveal that increased expression of GRK2 may act to compensate, at least in part, 126 
for the loss of mitochondria noted upon Myostatin treatment.  127 
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Materials and Methods 128 
 129 
Cell culture and treatments 130 
Mouse C2C12 myoblasts were obtained from American Type Culture Collection 131 
and their maintenance has been previously described (43). C2C12 myoblasts were 132 
expanded in myoblast proliferation medium (10% FBS, 1% P/S, and DMEM; 133 
Invitrogen) and differentiated into myotubes through serum withdrawal in 134 
differentiation medium (DMEM, 2% HS, and 1% P/S; Invitrogen) for 96h, to ensure 135 
complete differentiation of cultures. Doxycycline (2µg/ml) was added together with 136 
differentiation medium in order to induce the stable overexpression of GRK2.  137 
Recombinant Myostatin protein (Mstn) was purified from E. coli (62) and was used at a 138 
concentration of 3μg/ml for cell treatments, unless otherwise stated. For proteasome 139 
inhibitor studies C2C12 myotubes were treated with 3μg/ml recombinant Mstn for a 140 
total period of 24h. To block the activity of the proteasome MG132 (Sigma, St. Louis, 141 
MO) and Epoxomicin (Epox; Sigma) chemicals were added to C2C12 myotubes at 142 
10μm and 100nM final concentrations, respectively, 10h prior to harvesting the cells.  143 
The difference in total GRK2 seen in the absence of presence of the proteasome 144 
inhibitors represents the content of GRK2 that is being degraded through the ubiquitin-145 
proteasome system (29, 34). One independent experiment was performed with MG132 146 
with 3 biological replicates and one confirmatory experiment was performed with Epox.  147 
To block the lysosomal pathway, 100µM of chloroquine (Sigma) was added to 148 
myotubes in the presence or absence of Mstn (3μg/ml) for 12h. The difference in the 149 
protein levels of LC3-II between samples treated with and without chloroquine 150 
represents the level of autophagic flux in the cells (30, 77). Two different experiments 151 
were performed, each with one biological replicate.  152 
 153 
Generation of GRK2 stable cell lines  154 
Full length murine Grk2 cDNA (NM_130863.2) was PCR-amplified using the 155 
following primers: 5' - CC ACC GGT ATG CAG AAG TAT CTG GAG GAC CGA - 3' 156 
and 5' - ACC TGT ACA TCA GAG GCC GTT GGC ACT GCC ACG - 3' and cloned 157 
into the pGEM-T easy cloning vector (Promega).  After sequence verification, Grk2 was 158 
subcloned into the doxycycline-inducible PEM777 expression vector (28). Grk2-159 
PEM777 or empty-PEM777 (Control) were transfected into C2C12 myoblasts and cells 160 
using Lipofectamine 2000 (Invitrogen), as previously described (28). Following 3 days 161 
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of selection with puromycin (1µg/ml), stably transfected cells were harvested and 162 
expanded for further experimental procedures in the presence of 2µg/ml doxycycline. 163 
 164 
Assessment of mitochondrial respiration 165 
Mitochondrial respiration was assessed in vitro using the XFe24 extracellular 166 
flux analyser, and the XF Cell Mito Stress and Glycolysis Stress Test Kits, as per the 167 
manufacturer’s protocol (Agilent Technologies, Santa Clara, CA, USA), and as 168 
described previously (20, 52). For assessment of real-time mitochondrial respiration of 169 
myotubes, myoblasts were seeded (10,000 cells/well) onto XFe24 cell culture 170 
microplates and differentiated to form myotubes, as outlined above, in the presence of 171 
100ng/ml doxycycline for 48h. Cells were then treated with either 2µg/ml recombinant 172 
Mstn protein or an equal volume of dialysis buffer (Control) for a further 24h. The 173 
XFe24 sensor cartridge was hydrated overnight at 37˚C in a non-CO2 incubator. 30 174 
minutes prior to assay run, differentiation medium was replaced with Assay Medium 175 
(Agilent Technologies, Santa Clara, CA, USA) and cells were incubated at 37˚C in non-176 
CO2 incubator. Three measurements of oxygen consumption rate (OCR) and 177 
extracellular acidification rate (ECAR) were recorded pre- and post-injection of 1 µM 178 
Oligomycin (Oligo), 0.5µM FCCP and 0.5µM Antimycin/Rotenone (Ant/Rot) (Agilent 179 
Technologies, Santa Clara, CA, USA) (14).  180 
Using the Wave Desktop 2.3 software, seven parameters of mitochondrial 181 
respiration, basal OCR, ATP-linked OCR, OCR due to proton leak, maximal OCR, 182 
spare respiratory capacity, non-mitochondrial OCR and ECAR, were calculated from 183 
the bioenergetic profiles obtained from the XFe24 extracellular flux analyzer, which has 184 
been outlined in detail previously (22).  Briefly, basal OCR refers to the total baseline 185 
cellular respiration rate and includes respiration due to ATP production, proton leak 186 
(leak of protons across the inner mitochondrial membrane) and oxygen consumption 187 
due to non-mitochondrial processes (22).  ATP-linked oxygen consumption is 188 
determined through the addition of the ATP synthase inhibitor oligomycin, which 189 
effectively shuts down ATP production due to oxidative phosphorylation.  Any residual 190 
mitochondrial respiration/oxygen consumption noted at this point can then be attributed 191 
to proton leak (22).  Maximal OCR is determined through the addition of the proton 192 
ionophore (uncoupler) FCCP, which increases inner mitochondrial membrane 193 
permeability to protons, increasing oxygen consumption and allowing for the 194 
assessment of the maximal oxygen consumption/respiration possible in the cells (22).  195 
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Spare respiratory capacity is calculated through determining the difference between 196 
basal OCR and maximal OCR in the cells and this reflects the amount of extra oxygen 197 
consumption/ATP-production that can be achieved by the cells in response to increased 198 
energy demand (7). Non-mitochondrial respiration is the oxygen consumption due to 199 
non-mitochondrial processes.  Although not well defined, this has been attributed to 200 
such processes as hydrogen peroxide production (3) and the enzymatic activity of 201 
oxygenases (4). Assessment of extracellular acidification rate (ECAR) is primarily a 202 
measure of acid release and is related to lactic acid formation during glycolysis (15). 203 
Basal respiratory capacity was recorded at the third readout of OCR just prior to 204 
oligomycin injection, whereas mitochondrial respiration due to proton leak was 205 
recorded at 6th OCR readout, which is just prior to FCCP injection. Maximal respiration 206 
was recorded as the highest OCR measurement following FCCP injection. ATP-linked 207 
respiration and spare respiratory capacity were calculated by subtracting OCR due to 208 
treatment with oligomycin from basal respiration and basal respiration from maximal 209 
respiratory capacity, respectively. Non-mitochondrial respiration was taken as the 210 
minimum OCR measurement after injection of Ant/Rot and was subtracted from all 211 
respiratory calculations. Values were normalized to total protein content. Two 212 
independent experiments were performed to assess mitochondrial respiration, each 213 
containing 5 biological replicates. Three measurements per timepoint were assessed. 214 
 215 
RNA extraction and quantitative real time PCR (qPCR) 216 
Isolation of total RNA from C2C12 myotubes was performed using TRIZOL 217 
reagent, as per the manufacturer’s instructions (Invitrogen, Carlsbad, CA).  Synthesis of 218 
cDNA was achieved using the iScript system (Bio-Rad Laboratories, Inc., Hercules, 219 
CA), according to the manufacturer's protocol. Quantitative real-time PCR (qPCR) was 220 
undertaken using the SsoFast EvaGreen Supermix (Bio-Rad) and the CFX96 Real-Time 221 
PCR system (Bio-Rad).  Transcript levels of target genes were normalized against the 222 
expression of the housekeeping gene Gapdh.  Relative fold change in expression was 223 
calculated using the cycle threshold (ΔΔCT) method.  The sequences of the primers 224 
used in this manuscript are given in Table 1. All oligos pertaining to this study were 225 
purchased from Sigma Aldrich (Singapore). All qPCR in this study was performed once 226 
with 3 biological replicates and two technical replicates per sample/treatment. 227 
 228 
Immunoblotting (IB) 229 
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Proteins were isolated from myoblasts and myotubes using protein lysis buffer 230 
[50mM Tris, (pH 7.5), 250mM NaCl, 5mM EDTA, 0.1% NP-40, Complete protease 231 
inhibitor cocktail (Roche, Indianapolis, MN), 2mM NaF, 1mM Na3VO4, and 1mM 232 
phenylmethylsulfoxide (PMSF)].  Proteins were quantified using Bradford reagent (Bio-233 
Rad).  A total of 25 μg of each protein lysate was resolved on 4-12% BIS-TRIS precast 234 
gels (Invitrogen). Proteins were then transferred onto nitrocellulose membrane using 235 
either the Invitrogen iBlot® 2 dry transfer system or the XCell II SureLock™ wet 236 
transfer system (Invitrogen, Carlsbad, CA, USA).  Membranes were then blocked 237 
overnight at 4°C in 5% milk in 1× Tris-buffered saline-Tween 20 (TBST) and proteins 238 
were hybridized with specific primary antibodies for 3h in 5% milk/1× TBST.  239 
Membranes were then washed in 1× TBST, 5 times for 5 min each, before and after 1h 240 
incubation with a 1:5,000 dilution of respective secondary antibodies, either goat anti-241 
rabbit horse radish peroxidase (HRP) (Catalogue No:1706515; Bio-Rad, Hercules, CA, 242 
USA) or goat anti-mouse HRP (Catalogue No:1706516; Bio-Rad, Hercules, CA, USA) 243 
antibodies.  Antibody-bound proteins were detected using Western Lightning 244 
Chemiluminescence Reagent Plus (PerkinElmer, Boston, MA) and autoradiography 245 
films (Kodak). Protein levels were quantified and analyzed using the GS-800 calibrated 246 
densitometer (Bio-Rad) and analyzed using Quantity One imaging software (Bio-Rad).  247 
Details of the primary and secondary antibodies used in this study are provided in Table 248 
2.  The specificity of the anti-LC3B antibody has previously been demonstrated using a 249 
commercially available recombinant protein by Koukourakis et al., (2015) (31).  The 250 
anti-MFN1 antibody has been previously used to demonstrate increased levels of Mfn1 251 
protein in liver tissue of high fat diet fed mice and in hepatocytes that display a swollen 252 
mitochondrial morphology (25).  Previous target-specific siRNA knockdown studies 253 
have confirmed the specificity of the anti-P62 (76), anti-GRK2 (61), anti-PARKIN (36, 254 
67), anti-MFN2 (79), anti-DRP1 (37) and anti-FIS1 (46) antibodies used in the current 255 
study.  The number of experimental and biological replicates for IB analysis are detailed 256 
in relevant figure legends. 257 
 258 
Mitotracker Red staining and assessment of mitochondria morphology using confocal 259 
microscopy 260 
Following 72h doxycycline (2µg/mL) induction C2C12 myoblasts were seeded 261 
onto 8-well Permanox chambered slides, at a density of 5,000 cells per well. After 262 
overnight attachment, myoblasts were treated with recombinant Mstn protein (3µg/ml) 263 
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for 24h. To identify mitochondria, myoblasts were incubated for 30 min with 200 nM 264 
Mitotracker Red (CMX red Rosamine-based Mitotracker dye, Invitrogen). Cells were 265 
washed 3 times with PBS and subsequently fixed with paraformaldehyde (4%) in 266 
DMEM for 15 minutes. After fixation, cells were washed 3 times and were then 267 
mounted using SlowFade antifade reagent containing DAPI and analyzed using 268 
confocal microscopy (Nikon, 60X).  269 
To analyze mitochondrial morphology in control and GRK2 overexpressing 270 
C2C12 cells in the presence or absence of Mstn protein, the indices of mitochondrial 271 
interconnectivity (area/ perimeter ratio per mitochondrion), which is a measure of 272 
mitochondrial elongation, were quantified for each mitochondrion using the well-273 
validated NIH Image J macros (Mitochondrial and Mitophagy Morphology macros 274 
(available at http://imagejdocu.tudor.lu/), as previously described (59), with minor 275 
modifications. The particular Image J macro was originally described by Dagda et al., 276 
2009 (6) and importantly, has been used by several investigators since that time (5, 19, 277 
66).  Moreover, one recent study by Wiemerslage and Daewoo, (2016), further validated 278 
the Mitochondrial Morphology macro in dopamine neurons and analyzed the 279 
relationship and interdependency of individual parameters quantified by the macro 280 
(number of mitochondria, area, elongation, interconnectivity) under various conditions 281 
using principle component analysis (74). To quantify mitochondrial interconnectivity in 282 
C2C12 cell, between 10-15 high resolution RGB images (TIFF, 1020 x 1020 pixels) 283 
were captured for each condition using confocal microscopy and were analyzed for 284 
mitochondrial morphology.  In order to account for possible swelling of mitochondria, 285 
the area/perimeter were normalized for the minor axis of an ellipse that was “fitted” 286 
onto each mitochondrion analyzed by the macro. The interconnectivity ratio 287 
[(area/perimeter ratio)/minor axis] per cell were averaged for 50-100 mitochondria per 288 
cell, and subsequently averaged for the entire population size for each experimental 289 
condition (25-30 cells). A low average interconnectivity ratio for a specific 290 
experimental condition (e.g. Mstn treated cells relative to control untreated cells) is 291 
indicative of mitochondrial fragmentation (fission). 292 
 293 
Mitotracker Green Staining 294 
Following 72h doxycycline induction C2C12 myoblasts were seeded onto 6-well 295 
plates, at the density of 15,000 cells/cm2. The next day, cells were treated with 2μg/ml 296 
recombinant Mstn protein or an equal volume of dialysis buffer (Control) and incubated 297 
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at 37˚C, 5% CO2. After 24h, myoblasts were stained with 150nM MitoTracker® Green 298 
FM (Thermo Fisher Scientific, Waltham, MA, USA) for 20 minutes at 37˚C. Cells were 299 
washed twice with PBS and harvested in conical tubes by centrifuging at 300xg for 1 300 
minute. Cell pellets were resuspended in PBS and FACS analysis was performed to 301 
detect MitoTracker® Green FM fluorescence intensity using the FACSCanto™ II flow 302 
cytometry system (BD Biosciences, Franklin Lakes, NJ, USA). Fluorescent intensity of 303 
10,000 events from 3 replicate wells per experimental group were detected using the 304 
FITC channel and represented as mean fluorescent intensity (MFI). Two technical 305 
replicates were performed. 306 
 307 
Statistical Analysis 308 
Statistical analysis was performed using two-tail Student's-t-test and ANOVA, 309 
using the Bonferroni post-hoc test.  Data are expressed as mean ±SEM and results were 310 
considered significant at p<0.05. A description of experiment replicates is provided in 311 
relevant figure legends.  312 




Mstn promotes the loss of GRK2 protein via the Ubiquitin Proteasome Pathway (UPP) 315 
Initially we investigated whether or not Myostatin can modulate GRK2 316 
expression.  Immunoblot (IB) analysis revealed that treatment of C2C12 myotubes with 317 
recombinant Myostatin protein (Mstn) resulted in a ~70% decrease in GRK2 protein 318 
content after 24h treatment (Fig. 1A).  We further noted both a time- and dose-319 
dependent decrease in GRK2 protein levels in both C2C12 myoblasts and myotubes 320 
following treatment with Mstn (Fig. 1B and 1C).  However, Mstn-induced loss of 321 
GRK2 protein was more pronounced in C2C12 myotubes compared to Mstn-treated 322 
C2C12 myoblasts (Fig. 1B & 1C). 323 
Since Mstn has been shown to increase the activity of the UPP to promote loss 324 
of skeletal muscle proteins (44), we next evaluated whether or not Mstn promotes the 325 
loss of GRK2 protein through the UPP.  As shown in Fig. 1D and 1E, treatment of 326 
C2C12 myotubes with Mstn resulted in reduced protein levels of GRK2.  However, 327 
treatment of C2C12 cells with two different specific proteasome inhibitors (MG132 and 328 
Epoxomicin) was able to partially rescue the loss of GRK2 protein observed following 329 
Mstn treatment. (Fig. 1D & 1E).  330 
Taken together, these data suggest that Mstn is able to promote loss of GRK2 331 
protein, through activation of the Ubiquitin Proteasome Pathway (see summary; Fig. 4). 332 
 333 
GRK2 and Mstn have differential effects on mitochondrial mass and OXPHOS gene 334 
expression in myotube cultures 335 
It has been previously reported that GRK2 can target mitochondria in HEK293 336 
cells to increase mitochondrial function and enhance ATP generation (18).  On the other 337 
hand, Myostatin is a myokine that promotes mitochondrial dysfunction and loss (39).  338 
Thus, we next sought to determine: 1) the effect of GRK2 on mitochondrial mass and 339 
respiration in muscle cells, and 2) whether or not GRK2 may play a role in Mstn 340 
regulation of mitochondria. To facilitate this, we generated doxycycline-inducible 341 
GRK2 overexpressing C2C12 cells, with GRK2 overexpression in myotubes 342 
subsequently confirmed through both qPCR (Fig. 2A) and immunoblot analysis (Fig. 343 
2B). It is worth noting that despite significant over expression of GRK2, Mstn treatment 344 
was still able to reduce GRK2 protein levels, but not Grk2 mRNA expression, in 345 
GRK2-overexpressing C2C12 myotubes (Fig. 2A & 2B).  However, the levels of GRK2 346 
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protein remained elevated above endogenous levels compared to the control cell line, 347 
despite excess Mstn treatment (Fig. 2B). 348 
Initially we assessed mitochondrial mass through MitoTracker Green FM 349 
staining and subsequent FACS analysis. Results revealed a reduction in mitochondrial 350 
mass in response to Mstn treatment and an increase in mitochondrial mass upon 351 
overexpression of GRK2. (Fig. 2C). Conversely, a significant increase in mitochondrial 352 
mass was observed in GRK2-overexpressing myoblast cultures upon treatment with 353 
exogenous Mstn (Fig. 2C). Despite the increase in mitochondrial mass noted in control 354 
GRK2 overexpressing cells, the expression of critical OXPHOS genes (which encode 355 
for subunits of Complex I and Complex IV) was unaltered between untreated control 356 
and GRK2 overexpressing myotube cultures (Fig. 2D). Unexpectedly, the expression of 357 
the OXPHOS genes tended to increase in response to Mstn treatment (Fig. 2D), with the 358 
greatest increase in OXPHOS gene expression noted in Mstn treated GRK2 359 
overexpressing cells, when compared to Mstn treated control cells (Fig. 2D). 360 
 361 
GRK2 and Mstn influence mitochondrial fission and fusion in myotube cultures 362 
Next, we investigated the role of GRK2 and Mstn in mitochondrial 363 
structure/dynamics through analysis of mitochondrial fission and fusion markers. 364 
Western blot analysis revealed a significant reduction in the protein levels of 365 
mitochondrial fusion markers, MFN1 and MFN2, upon Mstn treatment, in both control 366 
and GRK2-overexpressing C2C12 myotubes (Fig. 3A & 3B). Furthermore, a significant 367 
increase in the levels of the mitochondrial fission marker proteins Drp1 and Fis1, and 368 
the mitochondrial E3 ligase PARKIN were observed upon Mstn treatment of control 369 
cells, with significantly increased levels of both Fis1 and PARKIN also noted in Mstn 370 
treated GRK2-overexpressing C2C12 myotubes (Fig. 3A & 3B). These data suggest that 371 
Mstn treatment is associated with reduced mitochondrial fusion and increased 372 
mitochondrial fission in C2C12 myotube cultures. A significant increase in the levels of 373 
Fis1was also noted in untreated GRK2-overexpressing C2C12 myotubes, when 374 
compared to untreated control cells; however, in contrast to what was observed 375 
following Mstn treatment, the levels of Drp1 and Parkin remained low and were in fact 376 
slightly reduced in untreated GRK2-overexpressing C2C12 myotubes, when compared 377 
to untreated controls (Fig. 3A & 3B). Interestingly, significantly increased levels of both 378 
MFN1 and MFN2 were observed in untreated GRK2-overexpressing C2C12 myotubes, 379 
when compared to controls (Fig. 3A & 3B).  380 
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We next stained control and GRK2-overexpressing myoblasts, treated with or 381 
without Mstn protein, with Mitotracker Red to visualize mitochondria and to assess for 382 
qualitative changes in mitochondria morphology (Fig. 3C).   Through using semi-383 
automated macros that determine the mitochondrial interconnectivity ratio 384 
(area/perimeter normalized to the minor axis of an ellipse) (59), we observed that 385 
untreated cells contained interconnected mitochondria, as evident by long tubular 386 
mitochondrial networks (Fig. 3C & 3D). However, Mstn treatment of cells led to a 387 
robust fragmentation of mitochondrial networks and a decreased mitochondrial 388 
interconnectivity ratio (Fig. 3D).  Paradoxically, inducible expression of GRK2 also 389 
resulted in a decreased mitochondrial interconnectivity ratio per cell (Fig. 3D). The 390 
combination of GRK2 overexpression and Mstn treatment resulted in a partial reversal 391 
of mitochondrial fragmentation induced by GRK2 alone, back to levels similar to cells 392 
treated with Mstn alone. However, the overall levels of fragmentation were still 393 
significantly lower when compared to untreated control cells (Fig. 3D). Based on the 394 
image analysis, our data shows that both GRK2 and Mstn treatment induce 395 
mitochondrial fragmentation/fission; although the molecular mechanism through which 396 
both proteins promote reduced mitochondrial interconnectivity is distinct, as per our 397 
Western blot data (altered MFN1/2 levels and increased Drp1 vs. Fis 1 levels; Fig. 3B).  398 
 399 
GRK2 overexpression prevents the increased autophagic flux observed in response to 400 
Mstn treatment 401 
It is well established that excess Myostatin leads to increased autophagy (35, 402 
73). Mitophagy is the selective process by which damaged/defective mitochondria are 403 
targeted for lysosomal-mediated degradation (30). Once different outer mitochondrial 404 
membrane-localized proteins are ubiquitinated, by E3 ligases including Parkin, 405 
mitochondria are “flagged” and targeted for degradation by the ubiquitin-binding 406 
adaptor protein P62/SQSTM1, which in turn associates with LC3 in the autophagosome, 407 
leading to the engulfment and degradation of mitochondria (51). During this process, 408 
the LC3 isoform I is conjugated to phosphatidylethanolamine to form a membrane-409 
bound form of LC3, termed LC3-II, which remains bound to autophagosome until it is 410 
targeted for degradation by the lysosome (68). To determine whether or not GRK2 411 
plays a role in autophagy, we next assessed autophagic flux in dialysis buffer and Mstn 412 
treated control and GRK2-overexpressing cells, in the presence or absence of 413 
chloroquine, a lysosomotropic agent that inhibits autophagy (64).  As observed in Fig. 414 
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3E, chloroquine treatment resulted in the accumulation of both p62 and LC3-II in 415 
control cells and of LC3-II in GRK2-overexpressing cells, consistent with a blockade in 416 
autophagy (Fig. 3E).  However, upon Mstn treatment, we observed a noticeable increase 417 
in p62 and LC3-II accumulation in chloroquine treated control cells, when compared to 418 
dialysis buffer treated controls (Fig. 3E), indicating increased autophagic flux in 419 
response to Mstn treatment.  Interestingly, no difference in p62 or LC3-II accumulation 420 
was observed in Mstn treated GRK2-overexpressing cells in the presence of 421 
chloroquine, when compared to control cells treated with chloroquine. These data 422 
suggest that over expression of GRK2 prevents the overt-autophagic flux induced upon 423 
Mstn treatment in myotube cultures, which is consistent with the increased 424 
mitochondrial mass noted in Mstn treated GRK2 overexpressing myoblasts (Fig. 2C).  425 
 426 
Mstn treatment impairs, while GRK2 overexpression increases, mitochondrial 427 
respiratory capacity in C2C12 myoblasts 428 
We next evaluated mitochondrial respiration in control and GRK2-429 
overexpressing myotubes by measuring OCR and ECAR by employing the XFe24 430 
Extracellular Flux Analyser (Agilent Technologies). In this system, OCR is used to 431 
measure real-time mitochondrial respiration and ECAR is used to measure glycolysis 432 
(14).  Extracellular flux analysis revealed a significant reduction in overall OCR in 433 
myotubes treated with Mstn (Fig. 3F & 3G). Subsequent quantification of real-time 434 
OCR data revealed a significant reduction in basal OCR, ATP-linked OCR, which 435 
reflects ATP production through oxidative phosphorylation, maximal OCR (maximal 436 
respiration possible in the cells) and spare respiratory capacity (amount of extra ATP-437 
production that can be achieved by the cells in response to increased energy demand) 438 
following Mstn treatment (Fig. 3G). In addition, Mstn treatment resulted in a significant 439 
reduction in the OCR due to proton-leak (leak of protons across the inner mitochondrial 440 
membrane) as well as non-mitochondrial respiration, which is OCR due to non-441 
mitochondrial processes in the cells (Fig. 3G). Interestingly, GRK2 overexpression led 442 
to a significant increase in the OCR of C2C12 myotubes (Fig. 3F & 3G), with a 443 
significant increase in basal OCR, maximal OCR, ATP-linked OCR and spare 444 
respiratory capacity noted upon overexpression of GRK2 (Fig. 3G), suggesting that 445 
elevated GRK2 has a positive effect on cellular respiration, enhancing maximal cell 446 
respiration and the potential to produce extra ATP in times of increased energy demand 447 
(Spare respiratory capacity). Importantly, we noted a statistically significant, albeit only 448 
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a very modest, reversal of Mstn-mediated repression of maximal OCR and spare 449 
respiratory capacity upon overexpression of GRK2 (Fig. 3G). The graph shown in Fig. 450 
3H is a visual representation of the metabolic phenotype in cells and reveals that 451 
untreated GRK2-overexpressing cells are more aerobic, when compared to untreated 452 
control cells (Fig. 3H). In addition, analysis revealed that Mstn treatment resulted in a 453 
robust increase in glycolysis and decreased aerobic respiration in myotube cultures, as 454 
evident by the increase in ECAR and concomitant reduction in OCR, respectively. 455 
Taken together these data suggest that while overexpression of GRK2 has a positive 456 
effect on mitochondrial respiration and can block Mstn-mediated autophagy in muscle 457 
cells, overexpression of GRK2 is not able to completely reverse the detrimental effect of 458 
Mstn on mitochondrial respiration (see summary; Fig. 4). 459 
460 




In this report, we have undertaken studies to explore GRK2 function in muscle 463 
cells and the role that GRK2 plays in Myostatin-mediated regulation of mitochondrial 464 
respiration. Herein, we have shown that overexpression of GRK2 in muscle cells leads 465 
to increased mitochondrial mass and respiration, as measured through oxygen 466 
consumption rate. In addition, our data suggests that GRK2 modulates mitochondrial 467 
dynamics, as inducible overexpression of GRK2 altered the levels of key regulators of 468 
mitochondrial fission and fusion and ultimately resulted in increased mitochondrial 469 
fragmentation. Excess Mstn also altered the levels of mitochondrial fusion and fission 470 
markers and further led to increased mitochondrial fragmentation; however, in contrast 471 
to what was observed in GRK2 overexpressing myoblasts, excess Mstn resulted in 472 
reduced mitochondrial mass, increased autophagic flux and impaired mitochondrial 473 
respiration in muscle cells.  Importantly, although elevated GRK2 levels was able to 474 
prevent the Mstn-mediated increase in autophagic flux, overexpression of GRK2 was 475 
unable to rescue the impaired mitochondrial respiration noted upon Mstn treatment.  476 
Our findings support a beneficial role for GRK2 in increasing mitochondrial respiration 477 
and preventing overt autophagy and loss of mitochondrial mass in skeletal muscle cells. 478 
As we have observed that Mstn represses the protein levels of GRK2 (Fig. 1 & 479 
2), but has no significant inhibitory effect on Grk2 mRNA expression (Fig. 2A), we 480 
propose that Mstn regulates GRK2 levels post-transcriptionally.  This is quite consistent 481 
with the involvement of the ubiquitin-proteasome pathway (UPP) in Mstn-induced 482 
repression of GRK2 protein levels that we have described (Fig. 1D & 1E).  Given this, 483 
we propose that GRK2 protein may be targeted for degradation through the UPP in 484 
response to Mstn treatment (Fig. 4).  Myostatin has been shown to upregulate both 485 
Atrogin-1 and MuRF1 E3 ligases to promote UPP-mediated protein degradation in 486 
conditions of muscle wasting (40, 44), thus we speculate that Myostatin may signal 487 
through the E3 ligases Atrogin-1 and/or MuRF1 to target and degrade GRK2 protein.  488 
Moreover, Salcedo et al., 2006 have revealed that in HeLa and HEK-293 cells GRK2 is 489 
targeted by the E3-ubiquitin ligase Mdm2 for degradation through the UPP upon β2-AR 490 
stimulation (60).  Given that Mdm2 is expressed in muscle cells (17) it is quite possible 491 
that Myostatin may signal through Mdm2 to regulate GRK2.  However, future studies 492 
will need to be performed to further clarify the specific molecular mechanism(s) 493 
through which Myostatin targets and represses GRK2 protein levels in muscle cells. 494 
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It is important highlight that we noted a more pronounced repression of GRK2 495 
protein levels in Mstn treated myotube cultures, when compared to myoblast cultures 496 
(Fig. 1B & 1C). Although the exact reason for this phenomenon remains to be defined, 497 
it is noteworthy to mention that the levels of the canonical Myostatin signaling target 498 
Smad3 (24) are increased during myogenic differentiation (9, 78). Thus, we speculate 499 
that the greater inhibitory effect of Myostatin on GRK2 may be due to increased 500 
availability of Smad3 and subsequent downstream signaling in myotube cultures.  501 
However, future studies will need to be undertaken to confirm this. 502 
Fusco et al. (2012),  have recently shown that GRK2 overexpression in HEK-503 
293 cells led to increased ATP production and mitochondrial biogenesis and that loss of 504 
GRK2 from skeletal muscle in vivo reduces ATP production (18).  In agreement with 505 
this, we find increased mitochondrial mass, oxygen consumption rates and cellular 506 
respiration, which is consistent with enhanced mitochondrial respiratory function, in 507 
GRK2 overexpressing skeletal muscle cells.  Increased oxygen consumption was also 508 
associated with reduced ECAR in GRK2 overexpressing myoblasts.  Similar results 509 
have been observed previously in myoblast cultures (10) and suggests that these cells 510 
rely on oxidative phosphorylation, as opposed to glycolysis, to meet cellular energy 511 
demands.  In contrast, upon Mstn addition to control cells, we observed significantly 512 
decreased oxygen consumption in muscle cells (Fig. 3F). In addition to reduced basal 513 
mitochondrial respiration, Mstn treatment led to significantly reduced maximal 514 
mitochondrial respiration when compared to controls. This could indicate diminished 515 
availability of substrate (although comparable medium constituents are maintained 516 
across all cell cultures), disruption of the electron transport chain or reduced 517 
mitochondrial mass (22). In agreement with this, reduced mitochondrial mass was seen 518 
in response to Mstn treatment of C2C12 cells (Fig. 2C). Together with reduced maximal 519 
respiration we also noted reduced spare respiratory capacity upon Mstn treatment, 520 
which suggests that Mstn treated cells may have reduced ability to respond to increased 521 
energy demand, when compared to control cells. We further observed reduced ATP-522 
linked respiration upon Mstn treatment, which could indicate a reduced requirement for 523 
ATP, reduced availability of substrate or importantly, impaired function of the electron 524 
transport chain and subsequent oxidative phosphorylation (22).  Moreover, reduced 525 
OCR and a concomitant increase in ECAR was noted in Mstn treated cells, consistent 526 
with a switch from predominantly aerobic respiration to glycolysis in these cells. Taken 527 
together, these observations are consistent with previously published work, revealing 528 
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that excess Mstn leads to mitochondrial dysfunction and reduced oxygen consumption 529 
(39). Unexpectedly, despite increased mitochondrial mass we did not find a rescue of 530 
Mstn-mediated impairment of oxygen consumption and cellular respiration upon 531 
overexpression of GRK2, although a very minor rescue of maximal respiration and 532 
related spare respiratory capacity was noted. Taken together, these data suggest that 533 
overexpression of GRK2 is not able to compensate for the deleterious effect of Mstn on 534 
mitochondrial respiration, and due to the increased mitochondrial mass noted, 535 
conceivably leads to an accumulation of dysfunctional mitochondrial in these cells.  536 
Increased expression of OXPHOS genes (Subunits of Complex I and IV) was 537 
noted in both Mstn treated control cells (albeit not statistically significant) and Mstn 538 
treated GRK2 overexpressing cells. A similar increase in complex IV OXPHOS gene 539 
expression has been observed in fibroblasts derived from patients with ATP synthase 540 
deficiency, independently of changes in mtDNA (21).  Moreover, increased mRNA 541 
expression of OXPHOS genes has been noted in diseases associated with additional 542 
mitochondrial complex deficiencies (57). Therefore, we speculate that the increased 543 
mRNA expression of OXPHOS genes observed in Mstn treated cells may act to 544 
compensate for the reduced oxygen consumption/mitochondrial respiration noted in 545 
response to Mstn treatment. 546 
It is noteworthy to mention that a more pronounced increase in OXPHOS gene 547 
expression was observed in GRK2-overexpressing cells following Mstn treatment. 548 
Previous work by Sorriento et al. (2013) have revealed that macrophages treated with 549 
LPS exhibit enhanced translocation and accumulation of GRK2 in mitochondria, which 550 
in turn was associated with elevated expression of cytochrome b and NADHd (complex 551 
III and I, respectively) (65). This may help to explain the OXPHOS gene expression 552 
pattern noted in Mstn treated GRK2 overexpressing myoblasts. However, further 553 
studies will need to be undertaken to confirm this hypothesis.   554 
In eukaryotic cells, mitochondrial content is tightly controlled through pathways 555 
that modulate mitochondrial biogenesis and mitochondrial clearance 556 
(autophagy/mitophagy) (8). Mstn robustly increases autophagic flux in myoblasts (Fig. 557 
3E). Moreover, we further find that Mstn treatment leads to mitochondrial 558 
fragmentation (Fig. 3D), impaired mitochondrial respiration (Fig. 3F & 3G) and a 559 
reduction in mitochondrial mass (Fig. 2C). Taken together these data suggest that Mstn 560 
treatment disrupts mitochondrial respiration and leads to decreased mitochondrial mass 561 
in muscle cells. It is important to mention that while the increased autophagic flux and 562 
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decreased mitochondrial mass is consistent with enhanced autophagy-mediated 563 
mitochondria clearance or mitophagy, a more direct measure of mitophagy would need 564 
to be performed to confirm this.  Interestingly, GRK2-overexpressing cells, when 565 
treated with Mstn, exhibited decreased autophagic flux, which was supported by 566 
reduced chloroquine-mediated accumulation of LC3-II and p62 in response to Mstn 567 
treatment, when compared to controls.  These data suggest that overexpression of 568 
GRK2 blocks the overt-autophagic flux induced by Mstn treatment, which would most 569 
certainly account for the increased mitochondrial content observed in Mstn treated 570 
GRK2 overexpressing myoblasts (Fig. 2C). Furthermore, given that GRK2 reduces 571 
autophagic flux in myoblasts and that Mstn treatment leads to a reduction in GRK2 572 
protein levels in muscle cells, it is interesting to surmise that Mstn may repress GRK2 573 
protein to facilitate autophagy-mediated clearance of mitochondria.  However, further 574 
work will need to be undertaken to validate this mechanism in muscle cells. 575 
The processes of mitochondrial fusion and fission are tightly regulated and are 576 
critically involved in governing mitochondria turnover, as evidenced by previous work 577 
(71).  Here, we show that GRK2-overexpressing cells exhibited increased levels of both 578 
mitochondrial fusion (Mfn1/2) and fission (Fis1) proteins, suggesting that 579 
overexpression of GRK2 promotes increased mitochondrial fission/fusion, which is 580 
consistent with recent work assessing GRK2 function during ionizing radiation-induced 581 
mitochondrial damage (16). In contrast to this, Mstn treatment tended to decrease the 582 
levels of both Mfn1 and Mfn2 in both control and GRK2 overexpressing myoblasts, 583 
suggesting that Mstn treatment may impair mitochondrial fusion. In addition, Mstn 584 
treatment led to elevated levels of the mitochondrial fission markers Drp1 and Fis1. 585 
However, it is interesting to note that while elevated Fis1 levels were maintained in 586 
Mstn treated GRK2 overexpressing myoblasts the Mstn-mediated increase in Drp1 was 587 
ablated in GRK2-overexpressing cells, revealing that GRK2 may have an inhibitory role 588 
in controlling Drp1 levels.  Furthermore, given that Mstn treatment leads to elevated 589 
Drp1 and Fis1 (Fig. 3A & 3B) and that overexpression of GRK2 increases the 590 
expression of Fis1, but not Drp1 (Fig. 3A & 3B), we propose that the changes in 591 
mitochondrial dynamics observed in response to either Mstn treatment or GRK2 592 
overexpression may occur through distinct mechanisms. Consistent with this, recent 593 
studies have revealed that Fis1 can regulate mitochondrial morphology independently of 594 
Drp1 (50).  595 
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It is important to mention that despite differential regulation of fusion and fission 596 
proteins by Mstn and GRK2, a similar reduction in mitochondrial interconnectivity, 597 
consistent with increased mitochondrial fragmentation, was noted between GRK2 598 
overexpressing myoblasts and Mstn treated control and GRK2 overexpressing cells, 599 
when compared to untreated controls (Fig. 3D). Importantly, despite a similar level of 600 
mitochondrial fragmentation, overexpression of GRK2 alone led to increased 601 
mitochondrial respiration.  We propose that the differences in mitochondrial respiration 602 
observed may be linked to maintenance of mitochondrial membrane potential in GRK2 603 
overexpressing cells.  Most certainly, previous work has revealed that fragmentation of 604 
mitochondria does not necessarily lead to reduced membrane potential (47) and more 605 
importantly, overexpression of GRK2 has been linked with maintenance of 606 
mitochondrial membrane potential in HEK293 cells in response to ionizing radiation-607 
induced damage (16).   Moreover, we find that the levels of the E3 ligase Parkin, which 608 
is recruited to damaged/defective mitochondria with low membrane potential to mediate 609 
their removal by autophagosomes (48), remained unchanged in control GRK2 610 
overexpressing cells. 611 
In conclusion, here we have described a beneficial role for GRK2 in regulating 612 
mitochondrial respiratory function and further reveal that excess GRK2 is able to 613 
influence autophagic flux in skeletal muscle cells (Fig. 4).  Although GRK2 has 614 
previously been shown to have a protective role in response to acute mitochondrial 615 
damage (16), we find that GRK2 is unable to prevent the significant deleterious effects 616 
of Mstn treatment on mitochondrial respiration in muscle cells (Fig. 4).     617 
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standard error of mean (SEM) 660 
transforming growth factor-β (TGF-β) 661 
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ubiquitin proteasome pathway (UPP) 664 
uncoupling protein (UCP) 665 
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Figure legends 937 
 938 
Figure 1: Excess Mstn leads to reduced GRK2 protein levels.  (A) left: immunoblot 939 
(IB) analysis of GRK2 protein expression in C2C12 myotubes after 24h treatment with 940 
(+) or without (-) Mstn.  Relevant bands from the IB are shown.  The levels of GAPDH 941 
were assessed as a loading control. Right: densitometric analysis of protein levels 942 
(GRK2) normalized to GAPDH levels. Values represent mean ± SEM; 5 biological 943 
replicates from 3 independent experiments were performed and analyzed; *p<0.05. 944 
Student t-test (B) IB analysis of GRK2 protein content in both myoblasts (left) and 945 
myotubes (right) treated with (+) or without (-) Mstn over a time course (3, 6, 16, 24 946 
and 48h).  The levels of GAPDH were assessed as a loading control. For each myoblast 947 
and myotube culture one independent experiment with one biological replicate was 948 
performed. (C) IB analysis of GRK2 protein levels in the absence (-) or presence (+) of 949 
increasing concentrations of Mstn protein (2, 3, 4 and 5µg/ml) in both myoblasts (left) 950 
and myotubes (right).  The levels of GAPDH were assessed as a loading control. For 951 
each myoblast and myotube culture one independent experiment with one biological 952 
replicate was performed.   (D) IB analysis of GRK2 protein levels in myotubes treated 953 
with (+) or without (-) Mstn, in the presence (+) or absence (-) of the proteasome 954 
inhibitor MG132 or vehicle control (DMSO).  The levels of GAPDH were assessed as a 955 
loading control, n=3 biological replicates from one independent experiment. (E) IB 956 
analysis of GRK2 protein levels in myotubes treated with (+) or without (-) Mstn, in the 957 
presence (+) or absence (-) of the proteasome inhibitor Epoxomicin (Epox) or vehicle 958 
control (DMSO).  The levels of GAPDH were assessed as a loading control. One 959 
biological replicate and one independent experiment was performed.  960 
 961 
Figure 2: Overexpression of GRK2 leads to increased mitochondrial content in 962 
muscle cells.  (A) qPCR analysis of Grk2 expression in stable Control and GRK2 963 
overexpressing C2C12 myotubes (GRK2) treated with (+) or without (-) Mstn for 24h.  964 
Gene expression was normalized to the endogenous control, Gapdh, using the ΔΔCT 965 
method. Values represent mean ± SEM; n=3 biological replicates from one independent 966 
experiment; ∗p < 0.05 vs Control - Mstn and #p<0.05 vs. GRK2 - Mstn.  One-Way 967 
ANOVA with Bonferroni correction was used for multiple comparisons.  (B) IB 968 
analysis of GRK2 protein levels in Control and stable GRK2 overexpressing C2C12 969 
myotubes (GRK2) treated with (+) or without (-) Mstn for 24h.  The levels of GAPDH 970 
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were assessed as a loading control. Representative of at least 3 independent 971 
experiments. (C) Graph showing quantitative analysis of mitotracker green staining in 972 
Control and stable GRK2 overexpressing myotubes following treatment with (-) or 973 
without (-) Mstn. Values represent mean ± SEM (2065± 5 for Control - Mstn, 1863±100 974 
for Control + Mstn, 2491±28 for GRK2 - Mstn and 2949±34 for GRK2 + Mstn); n=3 975 
biological replicates from one independent experiment. ∗p < 0.05 vs. Control - Mstn. 976 
#p<0.05 vs. GRK2 - Mstn and &p<0.05 vs. Control + Mstn. One-Way ANOVA with 977 
Bonferroni correction was used for multiple comparisons (D) qPCR analysis of 978 
mitochondrial encoded NADH dehydrogenase 1 (mt-Nd1), NADH dehydrogenase 4 979 
(mt-Nd4), cytochrome c oxidase I (mt-Co1), cytochrome c oxidase II (mt-Co2) and 980 
cytochrome c oxidase III (mt-Co3) expression in Control and stable GRK2 981 
overexpressing C2C12 myotubes (GRK2) treated with (+) or without (-) Mstn for 24h.  982 
Gene expression was normalized to the endogenous control, Gapdh, using the ΔΔCT 983 
method. Values represent mean ± SEM; n = 3 biological replicates from one 984 
independent experiment; ∗p < 0.05 vs. Control - Mstn. #p<0.05 vs. GRK2 - Mstn. One-985 
Way ANOVA with Bonferroni correction was used for multiple comparisons 986 
 987 
Figure 3: Overexpression of GRK2 in myoblasts enhances mitochondrial 988 
respiration and reverses Mstn-induced autophagic flux.  (A) IB analysis of 989 
Mitofusin 1 and 2 (Mfn1/2), Dynamin-related protein 1 (Drp1), mitochondrial fission 1 990 
protein (Fis1) and Parkin protein levels in Control and stable GRK2 overexpressing 991 
C2C12 myotubes (GRK2) treated with (+) or without (-) Mstn for 24h.  The levels of 992 
GAPDH were assessed as a loading control. n=3 biological replicates from one 993 
independent experiment. (B) Densitometric analysis of IB for Mfn1/2, Drp1, Fis1 and 994 
Parkin protein levels, normalized to GAPDH, in Control and stable C2C12 myotubes 995 
overexpressing GRK2 (GRK2) treated with (+) or without (-) Mstn for 24h.  Values 996 
represent mean ± SEM. *p<0.05 vs. Control - Mstn. #p<0.05 vs. GRK2 - Mstn. 997 
&p<0.05 vs. Control + Mstn. One-Way ANOVA with Bonferroni correction was used 998 
for multiple comparisons (C) Representative confocal micrographs of Control and 999 
GRK2 overexpressing myoblasts (GRK2) treated with (+) or without (-) Mstn and 1000 
stained with MitoTracker Red to visualize mitochondria. Nuclei were counterstained 1001 
with DAPI (Blue). Scale bar represents 40µm. The insert (white box) in the lower left 1002 
image was zoomed 40% from the original image and the white arrows are pointing to 1003 
fragmented mitochondria (small and circular). (D) Quantitative imaged-based analyses 1004 
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of mitochondrial interconnectivity ratio [(Area/perimeter)/minor axis] in 1005 
paraformaldehyde fixed control and GRK2 overexpressing C2C12 cells treated with (+) 1006 
or without (-) recombinant Mstn protein. The bar graph shows data compiled from a 1007 
representative experiment (data represents mean values ± SEM, n=20-35 biological 1008 
replicates per condition from one independent experiment). One-Way ANOVA with 1009 
Bonferroni correction was used for multiple comparisons. *p< 0.05. (E) IB analysis of 1010 
p62, LC3-I and LC3-II protein levels in control and stable GRK2 overexpressing 1011 
C2C12 myoblasts (GRK2) co-treated with (+) or without (-) Mstn for 12h in the 1012 
absence (-) or presence (+) of Chloroquine.  The levels of GAPDH were assessed as a 1013 
loading control. Blots are representative of two independent experiments. (F) Graph 1014 
showing the real-time OCR in Control and stable GRK2 overexpressing C2C12 1015 
myotubes (GRK2) treated with (+) or without (-) Mstn, as assessed by the Seahorse 1016 
XFe24 extracellular flux analyzer.  Time points where Oligomycin (Oligo), FCCP and 1017 
Antimycin/Rotenone (Ant/Rot) were injected (arrows) and the rate number where each 1018 
OCR was measured are indicated. Values represent mean ± SEM of three independent 1019 
measurements from 5 biological replicates.  (G) Graph showing quantification of basal, 1020 
maximal, ATP-linked and non-mitochondrial (Non-mito.) respiration, spare respiratory 1021 
capacity (S.R.C) and respiration due to proton leak in Control and stable GRK2 1022 
overexpressing C2C12 myotubes (GRK2) treated with (+) or without (-) Mstn. All OCR 1023 
values were normalized to total protein.  Values represent mean ± SEM of three 1024 
independent measurements from 5 biological replicates. Two different experiments 1025 
were performed. *p<0.05 vs. Control - Mstn. #p<0.05 vs. GRK2 - Mstn. &p<0.05 vs. 1026 
Control + Mstn. One-Way ANOVA with Bonferroni correction was used for multiple 1027 
comparisons.  (H) Graph showing OCR vs. ECAR in Control and stable GRK2 1028 
overexpressing C2C12 myotubes (GRK2) treated with (+) or without (-) Mstn. Values 1029 
represent mean ± SEM of three independent measurements from 5 biological replicates. 1030 
Two different experiments were performed.  1031 
 1032 
Figure 4: GRK2 regulates mitochondrial respiratory function and impairs Mstn-1033 
mediated autophagy in muscle cells.  Myostatin signaling (red lines and arrows) in 1034 
muscle cells results in loss of GRK2 protein through a mechanism involving the 1035 
ubiquitin-proteasome pathway. Furthermore, Mstn treatment leads to increased 1036 
mitochondrial fragmentation (consistent with mitochondrial fission), impaired 1037 
mitochondrial respiration and decreased mitochondrial mass, which was associated with 1038 
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increased autophagic flux in muscle cells.  Taken together, we surmise that Mstn may 1039 
act to stimulate autophagy-mediated clearance of mitochondria, or mitophagy, in muscle 1040 
cells. Overexpression of GRK2 (green lines and arrows), although not able to overcome 1041 
Mstn-induced impairment of mitochondrial respiration, blocked the increased 1042 
autophagic flux promoted by Mstn.  Moreover, elevated GRK2 levels resulted in 1043 
mitochondrial fragmentation, which was associated with an increase in both 1044 
mitochondrial mass and mitochondrial respiration. Given that overexpression of GRK2 1045 
resulted in mitochondrial fragmentation and altered the levels of critical mitochondrial 1046 
fusions/fission proteins we speculate a role for GRK2 in regulating the balance between 1047 
mitochondria fusion and fission in muscle cells (indicated by the ?).  Arrows represent 1048 
stimulation and blunt-ended lines represent inhibition. 1049 
  1050 
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Table 1 1051 
 1052 
Gene Symbol Forward Primer Sequence Reverse Primer Sequence 
Grk2 AGAGGGACGTCAATCGGAGA TTGCGGTACAGTTCCTGGTC 
mt-Co1 GCACTGGTGGATGCCTTCT TCTCTCGGGACTCCTTGATGA 
mt-Co2 ACGTGCAACACCTGAGCGGT GAAGGTGTCGGGCAGCAGGG 
mt-Co3 CTACCAAGGCCACCACACTC TCATGCTGCGGCTTCAAATC 
mt-Nd1 TCCGAGCATCTTATCCACGC GTATGGTGGTACTCCCGCTG 
mt-Nd4 CCACTGCTAATTGCCCTCAT CTTCAACATGGGCTTTTGGT 
Gapdh GATGATGACCCGTTTGGCTCC ACGCTCGTGGAAAGAAAAGA 
 1053 
Table 1: Sequences of primers. Table displaying gene symbols and forward and reverse 1054 
sequences of all primers used in the current study.    1055 
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Table 2 1056 
 1057 
Antibody Company Catalog No. Dilution Blocking Solution 
anti-GRK2 Santa Cruz sc-562 1:1000 5% milk 
anti-GAPDH Santa Cruz sc-32233 1:1000 5% milk 
anti-PARKIN Abcam ab15954 1:1000 5% milk 
anti-MFN1 Abcam ab126575 1:1000 5% milk 
anti-MFN2 Santa Cruz sc-100560 1:1000 5% milk 
anti-FIS1 Santa Cruz sc-98900 1:500 5% milk 
anti-DRP1 Santa Cruz sc-32898 1:5000 5% milk 
anti-P62 Abcam ab91526 1:5000 5% milk 
anti-LC3B Abcam NB100-2220 1:500 5% milk 
Goat anti-Mouse HRP Bio-rad 1706516 1:5000 5% milk 
Goat anti-Rabbit HRP Bio-rad 1706515 15000 5% milk 
 1058 
Table 2: Details of antibodies. Table displaying particulars of the antibodies used in the 1059 
current study.  Antibody name, source, catalog number, working dilution and blocking 1060 
solution are provided. 1061 







































3h 6h 16h 24h 48h





3h 6h 16h 24h 48h




Mstn- + - + - + - +
Myotubes











































































































































Mstn- - -- - - + + + + + +
GRK2Control









- - ++ - - ++
GRK2Control
























































































































































































































Downloaded from www.physiology.org/journal/ajpcell at James Cook Univ (137.219.203.165) on July 7, 2019.
